FIH Mobile : CAPITAL INJECTION IN A WHOLLY-OWNED SUBSIDIARY OF THE COMPANY

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

富智康集團有限公司

(incorporated in the Cayman Islands with limited liability)

(Stock Code: 2038)

This announcement is made by FIH Mobile Limited (the "Company") on a voluntary basis. Pursuant to applicable disclosure requirements laid down by the Taiwan Stock Exchange Corporation, Hon Hai Precision Industry Company Limited* ("Hon Hai") (the Company's ultimate controlling shareholder whose shares are listed on the Taiwan Stock Exchange Corporation) is required to make an announcement regarding the subject matter of this announcement. In order to facilitate timely dissemination of information to investors and potential investors in Hong Kong and Taiwan, the Company would like to make this announcement simultaneously upon such disclosure in Taiwan.

It is hereby announced that on 25 May 2017, the board of directors of 深圳市富宏訊科技 有限公司 (Shenzhen Fu Hong Xun Technology Co., Ltd.*) (an indirect wholly-owned

subsidiary of the Company incorporated in the People's Republic of China) ("FHX") has resolved that it will make a capital injection in 益富可視精密工業(深圳)有限公司

(InFocus Precision Industry (Shenzhen) Co., Ltd.*) ("InFocus"), its direct wholly-owned subsidiary incorporated in the People's Republic of China, in an aggregate amount of approximately RMB98.72 million (representing approximately 70.11% of the enlarged registered capital of InFocus) as additional working capital (the "Capital Injection"). It is expected that the Capital Injection shall be completed within three months from the date of this announcement.

Immediately following the Capital Injection, the total registered capital of InFocus will be increased to approximately RMB140.80 million, 100% equity interest of which will be held by FHX (being the sole registered holder of InFocus' entire equity interest immediately prior to and after the Capital Injection).

FHX recently acquired the then entire equity interest of InFocus from New Pacific Industrial Limited ("New Pacific") (to the best of knowledge, information and belief of the Company having made all reasonable enquiries, New Pacific is a third party independent of the Company and its subsidiaries) at approximately RMB 1.28 million.

The principal activities of InFocus are manufacturing, sales and distribution of handsets and related products, development of software technology and provision of information technology marketing services.

The Capital Injection does not constitute a notifiable transaction or a connected transaction for the Company under the Rules Governing the Listing of Securities on The Stock Exchange of Hong Kong Limited.

Hong Kong, 25 May 2017

By Order of the Board CHIH Yu Yang Acting Chairman

As at the date of this announcement, the board of directors of the Company comprises four executive directors, namely Mr. CHIH Yu Yang, Mr. WANG Chien Ho, Mr. HUANG Chin Hsien and Dr. LUO Zhongsheng; and three independent non-executive directors, namely Mr. LAU Siu Ki, Dr. Daniel Joseph MEHAN and Mr. TAO Yun Chih.

* For identification purposes only